Dual-Targeting Strategy to Repurpose Cetuximab with HFn Nanoconjugates for Immunotherapy of Triple-Negative Breast Cancer

  1. Linda Barbieri
  2. Lucia Salvioni
  3. Andrea Banfi
  4. Stefania Garbujo
  5. Luisa Fiandra
  6. Chiara Baioni
  7. Marco Giustra
  8. Lucia Morelli
  9. Gianni Frascotti
  10. Miriam Colombo
  11. Metello Innocenti
  12. Davide Prosperi
Read the full article See related articles

Discuss this preprint

Start a discussion What are Sciety discussions?

Listed in

This article is not in any list yet, why not save it to one of your lists.
Log in to save this article

Abstract

No abstract available

Article activity feed

  1. Version published to 10.1021/acsami.5c06626
  2. Version published to 10.1101/2025.02.03.634255 on bioRxiv